ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

MBRX Moleculin Biotech Inc

5.02
0.01 (0.20%)
取引時間後
最終更新日: 05:30:00
15分遅延
名称 銘柄コード 市場 種別
Moleculin Biotech Inc MBRX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.01 0.20% 5.02 05:30:00
始値 安値 高値 終値 前日終値
5.00 4.79 5.2466 5.02 5.01
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1821:30PRNUSEuropean Medicines Agency (EMA) Grants Orphan Drug..
2024/4/1021:30PRNUSMoleculin Announces Presentation of Positive Data..
2024/3/2823:45PRNUSMoleculin to Present at the MedInvest Biotech & Pharma..
2024/3/2722:25PRNUSMoleculin to Participate in the Virtual Investor Lunch..
2024/3/2722:05PRNUSMoleculin Announces U.S. Patent Issue Notification for..
2024/3/2520:30PRNUSMoleculin Announces Positive Interim Data in Annamycin..
2024/3/2305:05PRNUSMoleculin Reports Full Year 2023 Financial Results
2024/3/2020:30PRNUSMoleculin to Report Full Year 2023 Financial Results on..
2024/3/2020:15IHMARKETNEWSJPMorgan boosts dividends, Chipotle unveils 50:1 stock..
2024/3/2005:30PRNUSMoleculin Announces Reverse Stock Split
2024/3/1222:05PRNUSMoleculin to Present at the 36th Annual ROTH Conference
2024/2/2922:30EDGAR2Form 8-K - Current report
2024/2/2223:30EDGAR2Form 8-K - Current report
2024/2/1707:19EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/2/1523:15EDGAR2Form 8-K - Current report
2024/2/1506:36EDGAR2Form 8-K - Current report
2024/2/1506:33EDGAR2Form 8-K - Current report
2024/2/1314:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/2/0307:05EDGAR2Form S-1 - General form for registration of securities under..
2024/1/2422:50EDGAR2Form 8-K - Current report
2024/1/2422:50PRNUSMoleculin Announces 2023 Year-End Annamycin Clinical Trials..
2024/1/1707:00EDGAR2Form DEF 14A - Other definitive proxy statements
2024/1/0607:15EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/1/0607:14EDGAR2Form 8-K - Current report
2023/12/2721:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2307:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/2207:17EDGAR2Form 8-K - Current report
2023/12/2111:16PRNUSMoleculin Announces Pricing of $4.5 Million Registered..
2023/12/1822:55EDGAR2Form 8-K - Current report
2023/12/1122:55EDGAR2Form 8-K - Current report
2023/12/1122:50EDGAR2Form 8-K - Current report
2023/12/1122:50PRNUSMoleculin Presents Positive Interim Data from Phase 1B/2..
2023/11/2023:15EDGAR2Form 8-K - Current report
2023/11/1322:30EDGAR2Form 8-K - Current report
2023/11/1322:05EDGAR2Form 8-K - Current report
2023/11/1322:05PRNUSMoleculin Announces Positive Interim Data in Annamycin..
2023/11/1322:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1322:00EDGAR2Form 8-K - Current report
2023/11/1322:00PRNUSMoleculin Reports Third Quarter 2023 Financial Results
2023/11/0722:45EDGAR2Form 8-K - Current report
2023/11/0722:45PRNUSMoleculin to Report Third Quarter Financial Results on..
2023/11/0622:35EDGAR2Form 8-K - Current report
2023/11/0622:35PRNUSMoleculin Presents Positive Preliminary Efficacy Findings..
2023/11/0405:30EDGAR2Form 8-K - Current report
2023/10/1722:00EDGAR2Form 8-K - Current report
2023/10/1122:05PRNUSMoleculin to Participate in the Virtual Investor Ask the CEO..
2023/10/0706:15EDGAR2Form 8-K - Current report
2023/10/0221:40EDGAR2Form 8-K - Current report
2023/10/0221:40PRNUSMoleculin Doses First Subjects in Phase 2 Portion of..
2023/9/2121:50EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock